Theorem Clinical Research and Excel Life Sciences Form Strategic Relationship
Theorem Clinical Research and Excel Life Sciences have formed a strategic relationship.
Bio-Optronics Releases New Version of CTMS Technology
Bio-Optronics' Clinical Conductor CTMS team announced new features in the latest release of Clinical Conductor
MedNet Solutions Receives First Major Outside Financing
Funds to Accelerate iMedNet EDC Sales, Marketing and R&D Initiatives
French Plans to Cut Spending Through Off-label Medicines Jeopardizes Patient Safety and Challenges EU Regulatory Standards
The European Confederation of Pharmaceutical Entrepreneurs is very concerned about legislative developments on the use of off-label medicines in France.
EFPIA Unveils Action Plan for Lithuania
The Lithuanian Ministry of Health and EFPIA have announced a new Joint Working Agreement.
Orphan Drug Approvals Have Increased, But High Costs Pose Challenges for Patients, According to the Tufts Center for the Study of Drug Development
Although the pace of approvals for new orphan drugs have increased in the United States and Europe in recent years, patients are facing growing challenges accessing those drugs.
Top Reasons Patients Join Clinical Trials
Recruiting patients remains one of the most difficult challenges clinical trial sponsors face.
EMA Delays Decision on Clinical Trial Data until October
EMA has postponed formal adoption of the policy on publication of clinical trial data until its October 2, 2014 meeting
Tufts CSDD Report Finds Orphan Drug Approvals Have Increased, But Challenges Exist
ACRES and inVentiv Health Partner to Promote Operational Excellence and Shared, Global Clinical Research Platform
inVentiv Clinical Trial Recruitment Solutions and the Alliance for Clinical Research Excellence and Safety are partnering toward the development of a global system
Experts Tell Congress How to Streamline Clinical Trials
Key to accelerating the discovery and development of new medical therapies is to improve the clinical research process.
Management Board Delays Formal Adoption of EMA Publication of Clinical Trial Data Policy to October 2014
Further discussion required on wording and practical arrangements
EFPIA: French Legislation Undermines EU Regulatory Framework by Endorsing Off-label Use of Medicines for Economic Reasons
EFPIA criticized the intent of the French government to broadly enlarge the use of off-label drugs for economic reasons, even if there is an approved drug available.
French Legislation Comes in for Strong Criticism
The French government's intention to broadly enlarge the use of off-label drugs for economic reasons is wrong, according to a statement issued by EFPIA
Pharmaceutical Body EFPIA and Lithuanian Ministry of Health Galvanise Future Innovation and Improvements to Public Health with Landmark Joint Working Agreement
he Lithuanian Ministry of Health and EFPIA, the European Federation of Pharmaceutical Industries and Associations announced a significant new Joint Working Agreement that paves the way for protecting future health and growth in Lithuanian.
inVentiv's Otis Johnson Joins Site Optics and Quality Informatics Steering Committee for Development of Industry Wide Site-Based Performance Metrics and Informatics Standards
ACRP, ENACCT Partner on Cancer Trials Recruitment Professional Education
ACRP and ENACCT announced the integration of key ENACCT products and services into the current ACRP professional development portfolio.
Santen Pharmaceutical Facilitates Compliance, Promotes Safety, and Supports Growth with Oracle Argus Cloud Service
Scalable Cloud-Based Solution Provides High Availability and IT Cost Predictability
ACRP Expands Focus on Patient-centered Accrual Practices Through Integration of the Education Network to Advance Cancer Clinical Trials (ENACCT)
ACRP and the ENACCT are pleased to announce the integration of key ENACCT products and services into the current ACRP professional development portfolio.
Why are CRO Profits Shrinking While the Industry is Growing By Leaps And Bounds?
The pharmaceutical industry continues to outsource more clinical trials to contract research organizations each year...
Japanese Pharma Implements Oracle Argus Cloud Services
With the help of Oracle Health Sciences Consulting, Santen migrated its legacy data and rolled out the Oracle Argus Cloud Service solution in 10 months.
Grasping Banality Firmly in Future Pharma Policy
The European Union has managed to snatch defeat from the jaws of opportunity once more!
Power Past the Plateau to FSP Success
Functional service provider arrangements, or FSPs, are evolving beyond the clinical data management tasks they were designed to streamline.
Health Technology Assessment in Clinical Development: When to Bridge Research and Decision-Making
Health technology assessment is a field of analysis that evaluates the medical, social, ethical, and economic implications of development, diffusion, and use of health technology.
Eurofins Central Laboratory Expands US Lab Operations to Eurofins Campus in Lancaster, PA
Eurofins Central Laboratory is pleased to announce that is has achieved an important strategic milestone with the expansion and relocation of its US Central Laboratory Operations
Eurofins Central Laboratory Expands US Lab Operations to PA Campus
Eurofins Central Laboratory announced the expansion and relocation of its US Central Laboratory Operations to the company's Pharma Services campus in Lancaster, PA.
Principal Investigators Launches Website for Clinical Trial and Patient Referral Offers
Principal Investigators announced global availability of its online platform designed specifically to connect Medical Doctors with Pharma and R&D companies involved in clinical studies
The New and Easier Way to Find Patients and Begin Clinical Trials.
PAREXEL International Announces Acquisition of ATLAS Medical Services, a Provider of Clinical Research Services in Turkey
PAREXEL announced today that the Company has acquired all of the outstanding equity securities of ATLAS Medical Services
PAREXEL Acquires Clinical Services in Turkey, MENA
PAREXEL announced it has acquired all of the outstanding equity securities of ATLAS Medical Services.
